Cited by 3Advanced Glycation End Products researchChronic Kidney Disease and DiabetesAcute Kidney Injury Research

A race for RAGE ligands

Open access
Schleicher, Erwin D.·2010·Kidney International

Abstract

In experimental animals a causal involvement of the multiligand receptor for advanced glycation end products (RAGE) in the development of diabetic vascular complications has been demonstrated. However, the nature of RAGE ligands present in patients with diabetic nephropathy has not yet been defined; this leaves open the relevance of the RAGE system to the human disease.

Integrity signals

Registry

Crossref · 10.1038/ki.2010.146

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In overweight or obese men consuming high or low GI diets for 4 weeks, there are no differences in CRP, TNF-a, IL-6, fibrinogen, sTNFR2 or PAI-1 concentrations.

    “In another study, Shikany et al. (675) found no differences in CRP, TNF-a, IL-6, fibrinogen, sTNFR2 or PAI-1 concentrations when overweight or obese men consumed diets with high or low GI for 4 weeks.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schleicher, E. D.
Affiliations
University of Tübingen (DE)
Corresponding author
Schleicher, Erwin D.
Venue
Kidney International
Publisher
Elsevier BV
Published
2010-08
Volume
78
Issue
3
Pages
234-236
ISSN
0085-2538 (ISSN-L)
OpenAlex
W1991208194
Cited by
3
References
11
Citations by year
2015: 1
Type
journal article
Language
en
Open access
Locations
  • Kidney International (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
receptor for advanced glycation end products, RAGE ligands, diabetic nephropathy, diabetic vascular complications, advanced glycation end products, animal models
MeSH terms
Receptor for Advanced Glycation End Products, Animals, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Nephropathies, Humans, Ligands, Mice, Transgenic, Models, Biological, Molecular Weight, Protein Binding, Receptors, Immunologic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review